Cano Health, Inc.
CANO
CANO was delisted on the 2nd of February, 2024.
173 hedge funds and large institutions have $1.42B invested in Cano Health, Inc. in 2022 Q3 according to their latest regulatory filings, with 51 funds opening new positions, 54 increasing their positions, 42 reducing their positions, and 22 closing their positions.
1,072% more call options, than puts
Call options by funds: $212M | Put options by funds: $18.1M
400% more funds holding in top 10
Funds holding in top 10: 1 → 5 (+4)
132% more first-time investments, than exits
New positions opened: 51 | Existing positions closed: 22
96% more capital invested
Capital invested by funds: $726M → $1.42B (+$696M)
29% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 42
19% more funds holding
Funds holding: 145 → 173 (+28)
Top Buyers
| 1 |
MP
MFN Partners
Boston,
Massachusetts
|
+$44.2M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$22.7M |
| 3 |
Millennium Management
New York
|
+$16M |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$12.5M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$11.9M |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$39.7M |
| 2 |
MC
Maverick Capital
Dallas,
Texas
|
-$36.6M |
| 3 |
SC
Samlyn Capital
New York
|
-$23.9M |
| 4 |
Goldman Sachs
New York
|
-$23.7M |
| 5 |
D.E. Shaw & Co
New York
|
-$8.11M |
CANO Hedge Fund Activity: Q3 2022 in Review
173 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Cano Health, Inc. (CANO) for Q3 2022, worth a combined $1.42B — up 96% from $726M a quarter earlier.
Buyers outnumbered sellers: 51 funds opened new CANO positions and 22 closed out — a net gain of 29 holders — while 54 added to existing stakes and 42 trimmed.
The largest buyer was MFN Partners, opening a new position worth an estimated $44.2M. The largest seller was Citadel Advisors, cutting an estimated $39.7M.
- 173 institutional investors held Cano Health, Inc. (CANO) as of Q3 2022, up from 145 in Q2 2022.
- Funds reported $1.42B of Cano Health, Inc. stock for Q3 2022, up 96% quarter-over-quarter.
- 51 funds opened new Cano Health, Inc. positions in Q3 2022 and 22 closed out, a net change of +29 holders.
- The largest Cano Health, Inc. buyer in Q3 2022 was MFN Partners, an estimated $44.2M added.
- The largest Cano Health, Inc. seller in Q3 2022 was Citadel Advisors, an estimated $39.7M sold.
Based on aggregated 13F filings for Q3 2022.